Seminar Talk by Prof. Bart Deplancke on January 27 at 11:30 am

Prof. Bart Deplancke
Head of Laboratory of Systems Biology and Genetics, EPFL

Bart Deplancke and his team focus on understanding gene regulation, cellular differentiation, and tissue biology through innovative single-cell and high-throughput techniques (Live-Seq, external page Nature (2022-08-17)). By applying integrative genomic approaches and single-cell transcriptomics, they use adipogenesis as a model system to uncover the regulatory networks that drive cell heterogeneity. He contributed to the characterization of the Drosophila Genetic Reference Panel with the aim to facilitate genotype–phenotype mapping using the power of Drosophila genetics. 
 
Bart Deplancke received his Ph.D. degree in Immunobiology from the University of Illinois and performed his postdoctoral research at Harvard Medical School and University of Massachusetts where he developed a high-throughput protein-DNA interaction screening approach. In 2007, he established his own lab at Swiss Federal Institute of Technology Lausanne where he is now a Full Professor and Vice-Dean for Innovation. He is group leader at the Swiss Institute of Bioinformatics and he was awarded EMBO membership in 2023. He is also the co-founder of two Biotech companies (Genohm, acquired by Agilent in 2018 and Alithea Genomics).